The TWIST1 negative regulator, deactivated by HDAC5, was not reported, though independently, miR-22 is a known direct regulator of TWIST1 [306] where low miR-22 levels in osteosarcoma tumours contributes to EMT and disease progression through TWIST1 [306]. Here, TWIST1 is linked to neoplasm.